AstraZeneca plc (AZN) Receives Equal weight Rating from Barclays PLC


's stock had its "equal weight" rating restated by equities research analysts at Barclays PLC in a research note issued to investors on Tuesday. They presently have a GBX 5,000 target price on the biopharmaceutical company's stock.



from Biotech News